Enovis Corp Valuation
| ENOV Stock | USD 39.70 0.69 1.77% |
At this time, the firm appears to be undervalued. Enovis Corp shows a prevailing Real Value of $46.08 per share. The current price of the firm is $39.7. Our model computes the value of Enovis Corp from reviewing the firm fundamentals such as Profit Margin of (0.39) %, shares outstanding of 56.96 M, and Current Valuation of 3.47 B as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 0.8237 | Enterprise Value 3.5 B | Enterprise Value Ebitda 22.4229 | Price Sales 1.0592 | Forward PE 11.6144 |
Undervalued
Today
Please note that Enovis Corp's price fluctuation is very steady at this time. Calculation of the real value of Enovis Corp is based on 3 months time horizon. Increasing Enovis Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Enovis stock is determined by what a typical buyer is willing to pay for full or partial control of Enovis Corp. Since Enovis Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Enovis Stock. However, Enovis Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 39.7 | Real 46.08 | Target 66.0 | Hype 38.76 | Naive 39.67 |
The intrinsic value of Enovis Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Enovis Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Enovis Corp helps investors to forecast how Enovis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Enovis Corp more accurately as focusing exclusively on Enovis Corp's fundamentals will not take into account other important factors: Enovis Corp Total Value Analysis
Enovis Corp is currently estimated to have valuation of 3.47 B with market capitalization of 2.23 B, debt of 72.49 M, and cash on hands of 358.68 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Enovis Corp fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.47 B | 2.23 B | 72.49 M | 358.68 M |
Enovis Corp Investor Information
About 99.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enovis Corp has Price/Earnings To Growth (PEG) ratio of 1.9. The entity recorded a loss per share of 14.98. The firm had not issued any dividends in recent years. Enovis Corp had 581:1000 split on the 5th of April 2022. Based on the analysis of Enovis Corp's profitability, liquidity, and operating efficiency, Enovis Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Enovis Corp Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Enovis indicates not a very effective usage of assets in March.Enovis Corp Ownership Allocation
The majority of Enovis Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Enovis Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Enovis Corp. Please pay attention to any change in the institutional holdings of Enovis Corp as this could imply that something significant has changed or is about to change at the company.Enovis Corp Profitability Analysis
The company reported the previous year's revenue of 2.11 B. Net Loss for the year was (824.82 M) with profit before overhead, payroll, taxes, and interest of 1.25 B.About Enovis Corp Valuation
Our relative valuation model uses a comparative analysis of Enovis Corp. We calculate exposure to Enovis Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Enovis Corp's related companies.Enovis Corporation operates as a medical technology company worldwide. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies and directly under the DJO brand. Enovis Corp operates under Specialty Industrial Machinery classification in the United States and is traded on New York Stock Exchange. It employs 16200 people.
Enovis Corp Growth Indicators
Investing in growth stocks can be very risky. If the company such as Enovis Corp does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 55.3 M | |
| Quarterly Earnings Growth Y O Y | 1.531 | |
| Forward Price Earnings | 11.6144 |
Additional Tools for Enovis Stock Analysis
When running Enovis Corp's price analysis, check to measure Enovis Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enovis Corp is operating at the current time. Most of Enovis Corp's value examination focuses on studying past and present price action to predict the probability of Enovis Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enovis Corp's price. Additionally, you may evaluate how the addition of Enovis Corp to your portfolios can decrease your overall portfolio volatility.